Keywords
methadone
sleep disturbances
opioid
withdrawal.
Abstract
Restless legs syndrome is a frequent sleep disturbance, which usually involves an urgent desire to move the legs, associated with an unpleasant sensation and periodic movements of the legs during sleep. Its pathophysiology has been widely studied and is still not completely clear, and it is currently understood that it is influenced by personality, genetic and environmental factors. In this paper we describe 2 cases in which the suspension of methadone treatment was considered strongly associated with the presentation of restless legs syndrome in patients without previous diagnosis of this syndrome.References
1. Trotti LM, Bhadriraju S, Becker LA. Iron for restless legs syndrome. Cochrane Database Syst Rev. 2012;5 (5):CD007834. doi: 10.1002/14651858.CD007834.pub2.
2. Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283-95. DOI: 10.1016/j.smrv.2011.05.002.
3. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547-54. DOI: 10.1016/s0022-3999(02)00443-9.
4. Ekbom KA. Restless legs syndrome. Neurology. 1960;10:868-73. DOI: 10.1212/wnl.10.9.868.
5. Çurgunlu A, Döventaş A, Karadeniz D, Erdinçler DS, Oztürk AK, Karter Y, et al. Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey. Arch Gerontol Geriatr. 2012;55(1):73-6. DOI: 10.1016/j.archger.2011.06.002.
6. Srivanitchapoom P, Pandey S, Hallett M. Restless legs syndrome and pregnancy: a review. Parkinsonism Relat Disord. 2014;20(7):716-22. DOI: 10.1016/j.parkreldis.2014.03.027.
7. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4(8):465-75. DOI: 10.1016/S1474-4422(05)70139-3.
8. Silver N, Allen RP, Senerth J, Earley CJ. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med. 2011;12(5):440-4. DOI: 10.1016/j.sleep.2010.11.002.
9. Patatanian E, Claborn MK. Drug-induced restless legs syndrome. Ann Pharmacother. 2018;52(7):662-72. DOI: 10.1177/1060028018760296.
10. Anguelova GV, Vlak MHM, Kurvers AGY, Rijsman RM. Pharmacologic and nonpharmacologic treatment of restless legs syndrome. Sleep Med Clin. 2018;13(2):219-30. DOI: 10.1016/j.jsmc.2018.02.005.
11. Trenkwalder C, Zieglgänsberger W, Ahmedzai SH, Högl B. Pain, opioids, and sleep: implications for restless legs syndrome treatment. Sleep Med. 2017;31:78-85. DOI: 10.1016/j.sleep.2016.09.017.
12. De Biase S, Merlino G, Valente M, Gigli GL. Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects. Expert Opin Drug Metab Toxicol. 2016;12(9):1035-45. DOI: 10.1080/17425255.2016.1198320.
13. Salminen AV, Winkelmann J. Restless legs syndrome and other movement disorders of sleep-treatment update. Curr Treat Options Neurol. 2018;20(12):55. DOI: 10.1007/s11940-018-0540-3.
14. Park YM, Cho JH, Lim YS, Lee HJ, Kang SG, Kim L. The withdrawal from TDF therapy could induce transient RLS. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):419-20. DOI: 10.1016/j.pnpbp.2009.12.006.
15. Mackie SE, McHugh RK, McDermott K, Griffin ML, Winkelman JW, Weiss RD. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. J Subst Abuse Treat. 2017;73:35-9. DOI: 10.1016/j.jsat.2016.10.001.